Burkey BF

References (3)

Title : The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats - Duttaroy_2011_Eur.J.Pharmacol_650_703
Author(s) : Duttaroy A , Voelker F , Merriam K , Zhang X , Ren X , Subramanian K , Hughes TE , Burkey BF
Ref : European Journal of Pharmacology , 650 :703 , 2011
Abstract :
PubMedSearch : Duttaroy_2011_Eur.J.Pharmacol_650_703
PubMedID: 21070766

Title : Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited - Burkey_2008_Diabetes.Obes.Metab_10_1057
Author(s) : Burkey BF , Hoffmann PK , Hassiepen U , Trappe J , Juedes M , Foley JE
Ref : Diabetes Obes Metab , 10 :1057 , 2008
Abstract :
PubMedSearch : Burkey_2008_Diabetes.Obes.Metab_10_1057
PubMedID: 18422675

Title : 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties - Villhauer_2003_J.Med.Chem_46_2774
Author(s) : Villhauer EB , Brinkman JA , Naderi GB , Burkey BF , Dunning BE , Prasad K , Mangold BL , Russell ME , Hughes TE
Ref : Journal of Medicinal Chemistry , 46 :2774 , 2003
Abstract :
PubMedSearch : Villhauer_2003_J.Med.Chem_46_2774
PubMedID: 12801240
Gene_locus related to this paper: human-DPP4